- Moderna shares jump as much as 16% after company says its coronavirus vaccine trial produced 'robust' immune response CNBC
- Moderna coronavirus vaccine shows 'promising' safety and immune response results in published Phase 1 study, but more research is needed CNN
- Fauci: Coronavirus vaccine possible by the end of the year Reuters
- First COVID-19 vaccine tested in US poised for final testing The Associated Press
- Experimental COVID-19 vaccine safe, generates immune response | National Institutes of Health National Institutes of Health
- View Full Coverage on Google News
from Top stories - Google News https://ift.tt/2Wl7HF4
google News
No comments:
Post a Comment